Cargando…

Women’s priorities towards ovarian cancer testing: a best–worst scaling study

OBJECTIVE: To investigate the importance of key characteristics relating to diagnostic testing for ovarian cancer and to understand how previous test experience influences priorities. DESIGN: Case 1 best–worst scaling embedded in an online survey. SETTING: Primary care diagnostic testing in England...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Rebekah, Medina-Lara, Antonieta, Hamilton, Willie, Spencer, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438192/
https://www.ncbi.nlm.nih.gov/pubmed/36581964
http://dx.doi.org/10.1136/bmjopen-2022-061625
_version_ 1784781772988350464
author Hall, Rebekah
Medina-Lara, Antonieta
Hamilton, Willie
Spencer, Anne
author_facet Hall, Rebekah
Medina-Lara, Antonieta
Hamilton, Willie
Spencer, Anne
author_sort Hall, Rebekah
collection PubMed
description OBJECTIVE: To investigate the importance of key characteristics relating to diagnostic testing for ovarian cancer and to understand how previous test experience influences priorities. DESIGN: Case 1 best–worst scaling embedded in an online survey. SETTING: Primary care diagnostic testing in England and Wales. PARTICIPANTS: 150 women with ovaries over 40 years old living in England and Wales. METHODS: We used best–worst scaling, a preference-based survey method, to elicit the relative importance of 25 characteristics relating to ovarian cancer testing following a systematic review. Responses were modelled using conditional logit regression. Subgroup analysis investigated variations based on testing history. MAIN OUTCOME MEASURES: Relative importance scores. RESULTS: ‘Chance of dying from ovarian cancer’ (0.380, 95% CI 0.26 to 0.49) was the most important factor to respondents, closely followed by ‘test sensitivity’ (0.308, 95% CI 0.21 to 0.40). In contrast, ‘time away from usual activities’ (−0.244, 95% CI −0.33 to −0.15) and ‘gender of healthcare provider’ (−0.243, 95% CI −0.35 to −0.14) were least important to respondents overall. Women who had previously undergone testing placed higher importance on certain characteristics including ‘openness of healthcare providers’ and ‘chance of diagnosing another condition’ at the expense of reduced emphasis on characteristics such as ‘pain and discomfort’ and ‘time away from usual activities’. CONCLUSIONS: The results clearly demonstrated items at the extreme, which were most and least important to women considering ovarian cancer testing. Differences in priorities by testing history demonstrate an experience effect, whereby preferences adapt over time based on evidence and experience. Acknowledging these differences helps to identify underlying barriers and facilitators for women with no test experience as well as shortcomings of current service based on women with experience.
format Online
Article
Text
id pubmed-9438192
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94381922022-09-14 Women’s priorities towards ovarian cancer testing: a best–worst scaling study Hall, Rebekah Medina-Lara, Antonieta Hamilton, Willie Spencer, Anne BMJ Open Oncology OBJECTIVE: To investigate the importance of key characteristics relating to diagnostic testing for ovarian cancer and to understand how previous test experience influences priorities. DESIGN: Case 1 best–worst scaling embedded in an online survey. SETTING: Primary care diagnostic testing in England and Wales. PARTICIPANTS: 150 women with ovaries over 40 years old living in England and Wales. METHODS: We used best–worst scaling, a preference-based survey method, to elicit the relative importance of 25 characteristics relating to ovarian cancer testing following a systematic review. Responses were modelled using conditional logit regression. Subgroup analysis investigated variations based on testing history. MAIN OUTCOME MEASURES: Relative importance scores. RESULTS: ‘Chance of dying from ovarian cancer’ (0.380, 95% CI 0.26 to 0.49) was the most important factor to respondents, closely followed by ‘test sensitivity’ (0.308, 95% CI 0.21 to 0.40). In contrast, ‘time away from usual activities’ (−0.244, 95% CI −0.33 to −0.15) and ‘gender of healthcare provider’ (−0.243, 95% CI −0.35 to −0.14) were least important to respondents overall. Women who had previously undergone testing placed higher importance on certain characteristics including ‘openness of healthcare providers’ and ‘chance of diagnosing another condition’ at the expense of reduced emphasis on characteristics such as ‘pain and discomfort’ and ‘time away from usual activities’. CONCLUSIONS: The results clearly demonstrated items at the extreme, which were most and least important to women considering ovarian cancer testing. Differences in priorities by testing history demonstrate an experience effect, whereby preferences adapt over time based on evidence and experience. Acknowledging these differences helps to identify underlying barriers and facilitators for women with no test experience as well as shortcomings of current service based on women with experience. BMJ Publishing Group 2022-09-01 /pmc/articles/PMC9438192/ /pubmed/36581964 http://dx.doi.org/10.1136/bmjopen-2022-061625 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Oncology
Hall, Rebekah
Medina-Lara, Antonieta
Hamilton, Willie
Spencer, Anne
Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title_full Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title_fullStr Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title_full_unstemmed Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title_short Women’s priorities towards ovarian cancer testing: a best–worst scaling study
title_sort women’s priorities towards ovarian cancer testing: a best–worst scaling study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438192/
https://www.ncbi.nlm.nih.gov/pubmed/36581964
http://dx.doi.org/10.1136/bmjopen-2022-061625
work_keys_str_mv AT hallrebekah womensprioritiestowardsovariancancertestingabestworstscalingstudy
AT medinalaraantonieta womensprioritiestowardsovariancancertestingabestworstscalingstudy
AT hamiltonwillie womensprioritiestowardsovariancancertestingabestworstscalingstudy
AT spenceranne womensprioritiestowardsovariancancertestingabestworstscalingstudy